No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysis

OBJECTIVES: To compare the risk of serious adverse events, serious infections and death caused by methotrexate and biological disease-modifying antirheumatic drug (bDMARD) combination therapy versus a bDMARD prescribed as monotherapy in rheumatoid arthritis (RA). METHODS: A systematic literature rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Baradat, Claire, Degboé, Yannick, Constantin, Arnaud, Cantagrel, Alain, Ruyssen-Witrand, Adeline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337718/
https://www.ncbi.nlm.nih.gov/pubmed/28270933
http://dx.doi.org/10.1136/rmdopen-2016-000352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337718/
https://www.ncbi.nlm.nih.gov/pubmed/28270933
http://dx.doi.org/10.1136/rmdopen-2016-000352

Ejemplares similares